SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.961
AS - Asia 2.835
EU - Europa 2.575
SA - Sud America 486
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 77
OC - Oceania 6
Totale 12.225
Nazione #
US - Stati Uniti d'America 5.665
SG - Singapore 963
IT - Italia 721
CN - Cina 496
VN - Vietnam 443
HK - Hong Kong 385
BR - Brasile 365
DE - Germania 355
RU - Federazione Russa 335
SE - Svezia 282
CA - Canada 222
IE - Irlanda 205
FR - Francia 161
GB - Regno Unito 146
IN - India 101
BD - Bangladesh 96
UA - Ucraina 68
ID - Indonesia 53
IQ - Iraq 48
AT - Austria 47
FI - Finlandia 46
NL - Olanda 45
TR - Turchia 43
AR - Argentina 36
JP - Giappone 33
MX - Messico 33
DK - Danimarca 30
CO - Colombia 28
ES - Italia 28
PL - Polonia 28
ZA - Sudafrica 26
PK - Pakistan 22
KR - Corea 19
SA - Arabia Saudita 19
PH - Filippine 17
EC - Ecuador 16
BE - Belgio 13
UZ - Uzbekistan 12
KE - Kenya 11
VE - Venezuela 11
CH - Svizzera 10
CL - Cile 10
JM - Giamaica 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
MY - Malesia 9
CR - Costa Rica 8
CZ - Repubblica Ceca 8
LT - Lituania 8
OM - Oman 8
DZ - Algeria 7
MA - Marocco 7
BG - Bulgaria 6
GR - Grecia 6
IL - Israele 6
PE - Perù 6
PY - Paraguay 6
SN - Senegal 6
TT - Trinidad e Tobago 6
EG - Egitto 5
JO - Giordania 5
PT - Portogallo 5
TH - Thailandia 5
AU - Australia 4
EU - Europa 4
HU - Ungheria 4
LB - Libano 4
NI - Nicaragua 4
NP - Nepal 4
PA - Panama 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
MD - Moldavia 3
SY - Repubblica araba siriana 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
KG - Kirghizistan 2
LY - Libia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
Totale 11.933
Città #
Ann Arbor 894
Singapore 546
Ashburn 480
San Jose 431
Hong Kong 375
Frankfurt am Main 257
Chandler 244
Fairfield 225
Dublin 200
New York 184
Milan 172
Toronto 155
Wilmington 150
Ho Chi Minh City 123
Houston 123
Hanoi 119
Los Angeles 119
Woodbridge 111
Council Bluffs 97
Seattle 97
Dallas 96
Santa Clara 94
Chicago 93
Beijing 92
Paris 83
Princeton 72
Cambridge 70
Rome 59
Jacksonville 52
The Dalles 50
Hefei 46
Buffalo 44
Jakarta 43
Lauterbourg 38
Altamura 37
Dearborn 36
São Paulo 35
Columbus 34
Vienna 34
Lawrence 33
Moscow 33
Shanghai 31
Boardman 27
London 27
Atlanta 26
Tokyo 26
Phoenix 25
Denver 23
Pune 23
Brooklyn 22
Guangzhou 22
Baghdad 21
Haiphong 21
Helsinki 21
Orem 21
Johannesburg 20
Montreal 20
Nanjing 20
Warsaw 20
Nuremberg 19
Seoul 19
Amsterdam 18
Poplar 18
Stockholm 18
Andover 17
Boston 17
Fremont 17
Bogotá 15
Bologna 15
Munich 15
San Diego 15
Dong Ket 14
Ottawa 14
Lappeenranta 13
Brussels 12
Salt Lake City 12
Washington 12
Da Nang 11
Figino 11
Nairobi 11
Philadelphia 11
Rio de Janeiro 11
Tashkent 11
Turin 11
Changsha 10
Manchester 10
Thái Nguyên 10
Charlotte 9
Chennai 9
Hangzhou 9
Hải Dương 9
Jeddah 9
Kingston 9
Lachine 9
Quận Bình Thạnh 9
Biên Hòa 8
Catania 8
Falls Church 8
Mexico City 8
Shenyang 8
Totale 7.191
Nome #
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 612
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 549
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 428
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 384
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 381
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 374
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 361
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 357
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 354
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 353
HIV testing: A must for patients with inflammatory bowel disease 333
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 333
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 325
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 322
High rates of 30-day mortality in patients with cirrhosis and COVID-19 322
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 318
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 305
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 298
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 290
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 287
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 273
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 259
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 258
Unmasking tuberculosis in the era of antiretroviral treatment 257
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 257
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 253
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 246
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 245
Beware of biases in observational studies on anti-spike monoclonal antibodies 237
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis Service 231
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 224
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 224
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 210
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 202
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 189
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 186
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 182
Imported ciprofloxacin-resistant Neisseria meningitidis 182
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study 158
Pharmacotherapy of HIV: Focus on Etravirine 158
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 128
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 127
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 113
Reply 72
Reply 68
Totale 12.225
Categoria #
all - tutte 39.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 0 0 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.995 84 189 128 79 155 92 141 66 154 258 140 509
2025/20264.676 503 204 318 498 545 226 647 171 292 386 269 617
2026/2027975 174 225 424 152 0 0 0 0 0 0 0 0
Totale 12.225